FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2093717174> ?p ?o ?g. }

• W2093717174 endingPage "2247" @default.
• W2093717174 startingPage "2241" @default.
• W2093717174 abstract "Purpose Osteonecrosis of the jaw is a well-documented side effect of bisphosphonate (BP) use. Attempts have recently been made to predict the development of bisphosphonate-related osteonecrosis of the jaw (BRONJ). We prospectively investigated the predictive value of serum levels of C-terminal telopeptide of collagen I (CTX), bone-specific alkaline phosphatase, and parathyroid hormone for the development of BRONJ. Patients and Methods Data on the demographics, comorbidities, and BP treatment were collected from 78 patients scheduled for dentoalveolar surgery. Of the 78 patients, 51 had been treated with oral BPs and 27 had been treated with frequent intravenous infusions of BPs. Blood samples for CTX, bone-specific alkaline phosphatase, and parathyroid hormone measurements were taken preoperatively. Surgery was performed conservatively, and antibiotic medications were prescribed for 7 days. Results Of the 78 patients, 4 patients taking oral BPs (7.8%) and 14 receiving intravenous BPs (51.8%) developed BRONJ. A CTX level less than 150 pg/mL was significantly associated with BRONJ development, with an increased odds ratio of 5.268 (P = .004). The bone-specific alkaline phosphatase levels were significantly lower in patients taking oral BPs who developed BRONJ. The parathyroid hormone levels were similar in patients who did and did not develop BRONJ. Conclusion The incidence of BRONJ after oral surgery involving bone is greater among patients receiving frequent, intravenous infusions of BPs than among patients taking oral BPs. Although the measurement of serum levels of CTX is not a definitive predictor of the development of BRONJ, it might have an important role in the risk assessment before oral surgery. Osteonecrosis of the jaw is a well-documented side effect of bisphosphonate (BP) use. Attempts have recently been made to predict the development of bisphosphonate-related osteonecrosis of the jaw (BRONJ). We prospectively investigated the predictive value of serum levels of C-terminal telopeptide of collagen I (CTX), bone-specific alkaline phosphatase, and parathyroid hormone for the development of BRONJ. Data on the demographics, comorbidities, and BP treatment were collected from 78 patients scheduled for dentoalveolar surgery. Of the 78 patients, 51 had been treated with oral BPs and 27 had been treated with frequent intravenous infusions of BPs. Blood samples for CTX, bone-specific alkaline phosphatase, and parathyroid hormone measurements were taken preoperatively. Surgery was performed conservatively, and antibiotic medications were prescribed for 7 days. Of the 78 patients, 4 patients taking oral BPs (7.8%) and 14 receiving intravenous BPs (51.8%) developed BRONJ. A CTX level less than 150 pg/mL was significantly associated with BRONJ development, with an increased odds ratio of 5.268 (P = .004). The bone-specific alkaline phosphatase levels were significantly lower in patients taking oral BPs who developed BRONJ. The parathyroid hormone levels were similar in patients who did and did not develop BRONJ. The incidence of BRONJ after oral surgery involving bone is greater among patients receiving frequent, intravenous infusions of BPs than among patients taking oral BPs. Although the measurement of serum levels of CTX is not a definitive predictor of the development of BRONJ, it might have an important role in the risk assessment before oral surgery." @default.
• W2093717174 created "2016-06-24" @default.
• W2093717174 creator A5004312859 @default.
• W2093717174 creator A5011158714 @default.
• W2093717174 creator A5032409043 @default.
• W2093717174 creator A5033845345 @default.
• W2093717174 creator A5044935088 @default.
• W2093717174 creator A5062278720 @default.
• W2093717174 creator A5062656949 @default.
• W2093717174 creator A5064789610 @default.
• W2093717174 creator A5082551613 @default.
• W2093717174 date "2010-09-01" @default.
• W2093717174 modified "2023-10-11" @default.
• W2093717174 title "Serologic Bone Markers for Predicting Development of Osteonecrosis of the Jaw in Patients Receiving Bisphosphonates" @default.
• W2093717174 cites W147210144 @default.
• W2093717174 cites W1952385262 @default.
• W2093717174 cites W1964319106 @default.
• W2093717174 cites W1975868118 @default.
• W2093717174 cites W1984007159 @default.
• W2093717174 cites W1986662556 @default.
• W2093717174 cites W1989188477 @default.
• W2093717174 cites W1990119475 @default.
• W2093717174 cites W1990654348 @default.
• W2093717174 cites W1993952498 @default.
• W2093717174 cites W1995435702 @default.
• W2093717174 cites W1995807081 @default.
• W2093717174 cites W2003616531 @default.
• W2093717174 cites W2004878002 @default.
• W2093717174 cites W2007668592 @default.
• W2093717174 cites W201366182 @default.
• W2093717174 cites W2020365883 @default.
• W2093717174 cites W2022400490 @default.
• W2093717174 cites W2032829585 @default.
• W2093717174 cites W2034651674 @default.
• W2093717174 cites W2039010341 @default.
• W2093717174 cites W2043018502 @default.
• W2093717174 cites W2055352964 @default.
• W2093717174 cites W2055708086 @default.
• W2093717174 cites W2056380603 @default.
• W2093717174 cites W2060736857 @default.
• W2093717174 cites W2072396430 @default.
• W2093717174 cites W2075484386 @default.
• W2093717174 cites W2090539403 @default.
• W2093717174 cites W2102548701 @default.
• W2093717174 cites W2107208293 @default.
• W2093717174 cites W2112729869 @default.
• W2093717174 cites W2118377751 @default.
• W2093717174 cites W2132498623 @default.
• W2093717174 cites W2134304734 @default.
• W2093717174 cites W2151667145 @default.
• W2093717174 cites W2152741211 @default.
• W2093717174 cites W2160102488 @default.
• W2093717174 cites W2169512870 @default.
• W2093717174 cites W29459619 @default.
• W2093717174 cites W4239901602 @default.
• W2093717174 cites W4250407548 @default.
• W2093717174 cites W4254382561 @default.
• W2093717174 cites W4376595748 @default.
• W2093717174 doi "https://doi.org/10.1016/j.joms.2010.05.043" @default.
• W2093717174 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20728033" @default.
• W2093717174 hasPublicationYear "2010" @default.
• W2093717174 type Work @default.
• W2093717174 sameAs 2093717174 @default.
• W2093717174 citedByCount "82" @default.
• W2093717174 countsByYear W20937171742012 @default.
• W2093717174 countsByYear W20937171742013 @default.
• W2093717174 countsByYear W20937171742014 @default.
• W2093717174 countsByYear W20937171742015 @default.
• W2093717174 countsByYear W20937171742016 @default.
• W2093717174 countsByYear W20937171742017 @default.
• W2093717174 countsByYear W20937171742018 @default.
• W2093717174 countsByYear W20937171742019 @default.
• W2093717174 countsByYear W20937171742020 @default.
• W2093717174 countsByYear W20937171742021 @default.
• W2093717174 countsByYear W20937171742022 @default.
• W2093717174 countsByYear W20937171742023 @default.
• W2093717174 crossrefType "journal-article" @default.
• W2093717174 hasAuthorship W2093717174A5004312859 @default.
• W2093717174 hasAuthorship W2093717174A5011158714 @default.
• W2093717174 hasAuthorship W2093717174A5032409043 @default.
• W2093717174 hasAuthorship W2093717174A5033845345 @default.
• W2093717174 hasAuthorship W2093717174A5044935088 @default.
• W2093717174 hasAuthorship W2093717174A5062278720 @default.
• W2093717174 hasAuthorship W2093717174A5062656949 @default.
• W2093717174 hasAuthorship W2093717174A5064789610 @default.
• W2093717174 hasAuthorship W2093717174A5082551613 @default.
• W2093717174 hasConcept C120665830 @default.
• W2093717174 hasConcept C121332964 @default.
• W2093717174 hasConcept C125870589 @default.
• W2093717174 hasConcept C126322002 @default.
• W2093717174 hasConcept C131075544 @default.
• W2093717174 hasConcept C141071460 @default.
• W2093717174 hasConcept C156957248 @default.
• W2093717174 hasConcept C160160445 @default.
• W2093717174 hasConcept C170033053 @default.
• W2093717174 hasConcept C181199279 @default.
• W2093717174 hasConcept C185592680 @default.
• W2093717174 hasConcept C2776541429 @default.

• next